Abstract. A number of human cytokeratins are expressed during the development of stratified epithelia from one-layered polar epithelia and continue to be expressed in several adult epithelial tissues. For studies of the regulation of the synthesis of stratification-related cytokeratins in internal tissues, we have prepared cDNA and genomic clones encoding cytokeratin 4, as a representative of the basic (type II) cytokeratin subfamily and cytokeratin 15, as representative of the acidic (type I) subfamily, and determined their nucleotide sequences. The specific expression of mRNAs encoding these two polypeptides in certain stratified tissues and cultured cell lines is demonstrated by Northern blot hybridization. Hybridization in situ with antisense riboprobes and/or synthetic oligonucleotides shows the presence of cytokeratin 15 mRNA in all layers of esophagus, whereas cytokeratin 4 mRNA tends to be suprabasally enriched, although to degrees varying in different regions. We conclude that the expression of the genes encoding these stratification-related cytokeratins starts already in the basal cell layer and does not depend on vertical differentiation and detachment from the basal lamina. Our results also show that simple epithelial and stratificationrelated cytokeratins can be coexpressed in basal cell layers of certain stratified epithelia such as esophagus. Implications of these findings for epithelial differentiation and the formation of squamous cell carcinomas are discussed.
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PITHELIAL differentiation is usually characterized by the formation of intermediate-sized filaments (IFs) ~ of the cytokeratin type (20, 28, 85, 86) . The early embryonal epithelia, i.e., ecto-and endoderm, are simple polar epithelia and possess IFs of the most simple polypeptide composition, i.e., one representative of the acidic (type I) subfamily, i.e., cytokeratin 18, and one representative of the more basic (type II) cytokeratin subfamily, i.e., cytokeratin 8 (17, 42, 43, 48, 55, 70) . When during the development of certain organs the organization of one-layered polar epithelia changes and transforms to stratified epithelia, the synthesis of other cytokeratins, i.e., cytokeratins 1-6 and 9-17, is induced; these appear to be related to the stratification process (for early embryonal epithelia see references 3, 13, 55, 68, 92) . Among the earliest stratification-related cytokeratin polypeptides are cytokeratin 4, a type II polypeptide, and the type I cytokeratin 15, which are expressed during the embryonic development of all the diverse stratified epithelia studied so far, including epidermis (68) . Cytokeratin 4 seems to disappear in later stages of epidermal maturation, whereas cytokeratin 15 expression is continued in adult epidermis where it persists as a minor component (11, 30, 65, 1. Abbreviations used in this paper: IF, intermediate-sized filament: pfu, plaque-forming unit. 68, 73) . While cytokeratin 4 is one of the most abundant cytokeratins in several adult nonepidermat stratified epithelia such as oral and lingual mucosa, laryngeal and pharyngeal epithelia, epiglottis, esophagus, exocervix, and vagina and in squamous cell carcinomas derived from these tissues (4, 5, 31, 35, 65-69, 72, 73, 94) , cytokeratin 15 is usually detected in these epithelia only as a minor component.
Recent immunocytochemical studies using monoclonal antibodies specific for the stratification-related cytokeratins 4 and 13 have localized these proteins to the suprabasal layers of various stratified epithelia (91) , suggestive of a correlation of these two cytokeratins with the vertical differentiation process. In this respect, information about cytokeratin 15 is totally lacking as so far no antibody specific for this protein has been described. In order to learn more about the regulation of the selective appearance of stratification-related cytokeratins in different tissues as well as in different layers of the same epithelial tissue it was obviously necessary to have the adequate nucleic acid probes. So far human DNA clones are available only for some cytokeratins expressed in epidermis (e.g., 36, 37, 61, 82, 88) and certain simple epithelia (34, 56, 71, 80) . In the present study, we describe the cloning of genes encoding cytokeratins 4 and 15 and their amino acid sequences, and show their specific expression in various squamous epithelial tissues and cultured cell lines.
Materials and Methods

Tissue Preparation
Tissue samples were obtained during surgery for various indications (Surgery Clinics, Women's Hospital, and Dermatology Department, Mannhelm, and University of Heidelberg-Mannheim Medical School). Small pieces of epithelium were frozen in liquid nitrogen or in isopentane precooled in liquid nitrogen to -130~ within 15 min after surgical removal, For RNA extraction epithelial cell layers were either quickly peeled off with forceps or scraped off with a scalpel. The collected epithelial material was either frozen in liquid nitrogen or immediately homogenized in 4 M guanidinium isothiocyanate buffer (in 0.1 M Tris-HC1, pH 7.5, 10 mM dithiothreitol, (DTT), and 5 mM EDTA).
Library Screening and DNA Sequencing
A cDNA library in Lgtl0 constructed from poly(A)+-RNA of the vulvar carcinoma cell line A-431 was kindly provided by Dr. A. Ullrich (Genentech, South San Francisco, CA; cf. 90). A genomic library in European Molecular Biology Laboratory (EMBL)-3 phage constructed from partially digested human blood was kindly obtained from Dr. R. Cortese (EMBL, Heidelberg, Federal Republic of Germany (FRG); cf. 7). Screening and DNA extraction procedures were performed essentially as described (56) . As nick-translated screening probe we used a mixture of combined cDNA inserts excised from various bovine type I and II cytokeratin cDNA clones, including pKBla, pKBlb/c, pKBIII, pKBIV, pKBVI, pKBVll, pKB8 I, and pKBI9 ~ (2, (45) (46) (47) 60) . 120,000 phages were plated from the amplified cDNA library. The EcoRl inserts of the purified phage DNAs were subcloned into the pTZI8 R vector (Pharmacia, Uppsala, Sweden). Both strands of the clones pKH4 ~ (encoding cytokeratin 4) and pKHI5 t (encoding cytokeratin 15) were sequenced according to the standard protocol of Maxam and Gilbert (62) . The nick-translated Y-specific Xhol fragment of clone pKHI5 ~ was subsequently used to screen 1.2 • 106 phages of the genomic library. Fragments of one of the three selected genomic clones (~.KH152) were purified, subcloned into the transcription vectors Bluescribe and Bluescript (Stratagene, San Diego, CA), and sequenced.
Construction of a Y-specific Subclone and In Vitro Expression of a Reconstructed Complete
cDNA Clone for Cytokeratin 15
Two polynucleotides of 75 residues, taken from both strands of the 3'-noncoding region (residues 1606-1680; see Results), were synthesized and purified as described (57) , attached to EcoRI linkers and cloned into the transcription vector Bluescript (clone pKH152). For the construction of a complete hybrid cDNA clone encoding cytokeratin 15, the KpnI/Kpnl fragment of 479 nucleotides of the genomic phage clone ~,KHI52 which contains a large part of the first exon was ligated to the unique Kpnl site of the cDNA clone pKHI5 ~. The BamHI/EcoRI insert of this clone was further subcloned into Bluescript (clone pKH15~). The transcript of pKHI53 obtained with T7 RNA-polymerase was translated in vitro (cf. 59) and the translational product was analyzed by coelectrophoresis with cytoskeletal proteins from A-431 cells or tissues (cf. 53, 60, 65) .
RNA Preparation and Northern Blot Analysis
Total RNA and poly(A)+-RNA were extracted from cultured human cells of the vulvar epidermoid carcinoma-derived cell line A-431, including clonal sublines expressing cytokeratin 4 as well as clones with high relative contents of either cytokeratin 13 (clone E3) or cytokeratin 15 (clone E6; for different sublines, see also reference 65), the breast carcinoma cell line MCF-7, the pharyngeal carcinoma-derived cell line Detroit-562, and the bladder carcinoma-derived cell line RT-112 (65, 66, 73) . For comparison, RNA from SV40-transformed human fibroblasts (27) was used. Culture dishes were rinsed three times with PBS. After carefully decanting the buffer, the cells were directly suspended in the 4 M guanidinium isothiocyanate buffer (see above), scraped off, and homogenized with an Ultra Turrax blender (Janke and Kunkel KG, Staufen, FRG). RNA was extracted from homogenates of cultured cells and from tissue samples essentially as described (56) . Poly(A)+-RNA was bound to an oligo-dT cellulose matrix and eluted as described by Kreis et al. (53) . Purified RNA was electrophoretically separated on 1.2 % agarose gels containing formaldehyde, blotted onto Gene Screen Plus and hybridized with RNA polymerase in vitro transcripts (56) .
Hybrid Selection and Translation In Vitro
Poly(A)+-RNA from A-431 cells (clones E3 and E6) or total RNA from Detroit-562 cells were hybridized to filter-bound subclones and selected mRNAs were translated in vitro using [35S]methionine as label (cf. 46, 60) . In experiments with the short subclone pKHI52, the hybridization temperature was lowered to 32~ and the bound RNA was successively removed by washes at increasing temperature. Two-dimensional gel electrophoresis was performed as coelectrophoresis of the in vitro translation products with an excess of unlabeled reference proteins and cytoskeletal proteins from A-431 cells or from esophageal tissue to allow the identification of the translational products (cf. 46, 58, 60, 65) .
Hybridization In Situ
Upon linearization of pKH4 ~ with HindIII and pKHl51 with BglI riboprobes were obtained that could be radioactively labeled by in vitro transcription with T7 RNA polymerase (56) . The 75-mer polynucleotide complementary to residues 1606-1680 (see above) was 5' end-labeled with [~,-32P]ATP using polynucleotide kinase and purified (cf. 57). The protocol for hybridization in situ was as described (9, 56) . Posthybridization treatment with RNase A was omitted when synthetic oligonucleotide probes were used.
Immunofluorescence Microscopy
4-5 Ixm cryostat sections of various tissues, including esophagus, epidermis, endo-and exocervix, vagina, tongue, lung, liver, and colon were processed as described (cf. 1). Monoclonal antibody 6BI0, specific for cytokeratin 4 (91) was kindly provided by Dr. G. van Muijen (University of Leiden, Netherlands).
Results
Immunocytochemical Localization of Stratification-related C ytokeratins in Internal Epithelia
Most internal squamous stratified epithelia are characterized by abundant amounts of cytokeratins 4 and 13, together with usually lesser amounts of cytokeratins 5, 6, 14, and 15 (cf. 73). In immunofluorescence microscopy, monoclonal antibodies specific for cytokeratins 4 and 13 stain, in the epithelia studied so far, all suprabasal cell layers rather uniformly but leave the basal cell layer unstained. For example, Fig. 1 , a and b shows the reactivity of the cytokeratin 4-specific monoclonal antibody 6B10 on esophagus, and similar pictures were also obtained with other stratified tissues (not shown) such as exocervix (cf. 22), vagina, oral, and lingual mucosa (e.g., 72). Remarkably, cytokeratin 4-specific immunostaining is not restricted to the stratified epithelium but positive reaction can also be seen in certain cells or cell clusters in the ducts of mucous and serous glands of the esophageal submucosa (Fig. 1, c and d ; cf. 40). As antibodies specific for cytokeratins 5, 6, 14, or 15 are not available the tissue distribution of these cytokeratins in internal epithelia is not known.
Isolation of cDNA Clones Encoding Human Cytokeratins
A ~,gtl0 cDNA library of the cell line A-431 was initially chosen because these cells coexpress a total of up to eleven different cytokeratins (65, 73) , including cytokeratins 5, 6, 13-15, and at least in some sublines, small amounts of cytokeratin 4 as well (unpublished data; 91). 1.2 • 105 plaqueforming units (pfu) of the amplified library were screened with a mixed probe containing the nick-translated inserts of 
Identification of a cDNA Clone Encoding Human Cytokeratin 4
After hybridization with RNA from A-431 cells, the subclone pKH4 ~ selected a mRNA which yielded, on release and in vitro translation, a barely detectable product which did not comigrate with any of the major cytokeratins present in A-431 cells (data not shown). However, a hybrid selection-translation experiment with RNA from Detroit-562 cells revealed a distinct translational product which comigrated with authentic cytokeratin 4 ( Fig. 2, a and b) .
When RNA extracted from diverse tissues and cultured cell lines was probed for mRNA encoding cytokeratin 4 in Northern blot hybridization experiments, using specific riboprobes derived from clone pKH4 r (for details, see Fig.  3 ), all those tissues and cells in which this cytokeratin had been found by immunocytochemistry and/or gel electrophoresis were also positive in this test (Fig. 2, c-e) . In contrast, epithelial cell cultures as well as simple (colon) and squamous stratified (epidermis) epithelial tissues, in which this cytokeratin has not been detected at the protein level, were negative in Northern blot hybridization with this probe (Fig. 
2, c-e).
These results also show that, under our stringency conditions of hybridization, cross-hybridization with mRNAs for other cytokeratin members of the same subfamily did not occur, thus allowing the specific detection of cytokeratin 4 mRNA (cf. 46; see, however, 32, 49).
The by far highest concentration of mRNA for cytokeratin 4 was found in esophageal RNA ( 
Sequence Characteristics of Human Cytokeratin 4
Sequencing shows that the 1760-bp insert of clone pKH4 ~ offers an open reading frame encoding 408 amino acids ( coil 2 into the tail domain is the typical "consensus sequence" TYR(X)LLEG present in all IF proteins (32, 36, 37, 73, 84, 93) . Comparisons with other protein sequences identified the murine Mr 57,000 (mol wt 56,429) cytokeratin, expressed predominantly in tongue and forestomach (51) , as the protein most closely related to pKH4 ~ (Fig. 4) . The amino acid identity of ~8 0 % between human cytokeratin 4 and this murine cytokeratin was considerably higher than that with human cytokeratin 6 (65 %; 37, 88), indicating that the mouse Mr 57,000 cytokeratin may be the equivalent to human cytokeratin 4. None of the various bovine type II cytokeratin sequences determined in our laboratory (cf. 45, 47, 58) showed a similarly close relationship to human cytokeratin 4. The tail region of human cytokeratin 4 is exceptionally rich in hydroxyamino acids (40%) but contains less glycine residues and glycine-rich oligopeptide repeats than several epidermal type II cytokeratins (37, 45, 82 Fig. 2 a) , together with proteins of the translational assay, coelectrophoresed with reference protcins (as in Fig. 2 a) 
Identification of a cDNA and a Genomic Clone Encoding Human Cytokeratin 15
When the cDNA clone pKH15 ~ and the reconstructed cDNA clone pKH153 were used in hybrid selection-translation experiments with RNA from A-431 cells of clone E3 it specifically selected a mRNA that was translated in vitro into a polypeptide comigrating with authentic cytokeratin 13 (e.g., Fig. 5, a and b) . However, results obtained in Northern blot hybridizations, notably with epidermal mRNA, and in mRNA hybrid-release experiments with certain clonal A-431 sublines containing lower amounts of cytokeratin 13 but large amounts of cytokeratin 15 such as clone E6 were incompatible with the interpretation of a cytokeratin 13-encoding cDNA (data not shown; see also below). For an unequivocal identification of these cDNA clones we therefore used clone pKH153 for in vitro synthesis of the corresponding mRNA and polypeptide which was then found to comigrate, in gel electrophoresis, with cytokeratin 15 and not with cytokeratin 13 (Fig. 5, c-f , presents results from two different A-431 sublines, E3 and E6). This indicated that the protein encoded by this clone is in fact cytokeratin 15 and that cytokeratins 13 and 15 are very closely related. To examine this interpretation we synthesized a polynucleotide of 75 residues located in the 3'-noncoding region, i.e., the region showing the highest sequence divergence within the type I cytokeratin multigene family (46, 47, 74, 79) . This probe (pKH152) allowed the distinction between cytokeratins 13 and 15 as demonstrated in the hybrid selection experiment shown in Fig. 5 , g and h.
Northern blot experiments identified a cytokeratin 15 mRNA of,~l.9 kb in A-431 cells (Fig. 6, lanes 1 and 7) and in certain stratified epithelial tissues, including epidermis (Fig. 6, lane 3) and esophagus (Fig. 6, lane 8) . Only a very weak signal was obtained in cultured cells of the line Detroit 562 (Fig. 6, lane 6 ) whereas simple epithelia and various cell lines derived therefrom were negative (e.g., Fig. 6 , lanes 2, 5, and 9).
Sequence Characteristics of Human Cytokeratin 15
The '~l.3-kb insert of the cDNA clone pKH15 ~ extends from within coil la to the 3'-end, including a short poly-A stretch. A 3'-specific, nick-translated fragment of ~450 nucleotides of this clone was used to screen a human genomic library. The isolated phage clone ~,KH152 contained the complete gene encoding human cytokeratin 15. Nucleic acid sequencing proved the identity of the cDNA and the genomic clone. The nucleic acid sequence of human cytokeratin 15 as deduced from cDNA clone pKH15 ~ and the 479-bp Kpnl fragment of the genomic clone ~KH152 encompasses '~1.7 kb (Fig. 7) . S1 nuclease mapping (data not shown) indicated that the transcription started at the KpnI site at the start of the sequence presented in Fig. 7 , most probably at position 4, thus defining a short 58-nucleotidelong, 5'-nontranslated region. The cDNA terminates 23 bp downstream of a typical polyadenylation signal with a short poly-(A) stretch.
The coding region of cytokeratin 15 defines a polypeptide of 456 amino acids, amounting to a total mol wt of 49,170 including the initial methonine which is probably lost after translation. This value is in agreement with that estimated from SDS-PAGE analyses (Mr 50,000; cf. ll, 24, 65, 96) . The 96-amino acid-long head domain displays features com- The structure predicted for the a-helical rod domain is in agreement with the basic IF conformation (for reviews, see 31, 82, 93) . The three coiled-coil domains defined by the heptad repeats are interrupted by two spacer sequences, and the "consensus sequence" TYR(X)LLEG is recognized at the end of this domain.
The tail region contains only a short stretch rich in glycine and serine. In contrast to cytokeratin 4 a heptapeptide motif DGQVVSS similar to the hallmark sequence DGKvLVS~ mentioned above, which shows a striking resemblance to the core motif of calcium-binding proteins of the "EF-finger" type (19) , is located close to the carboxy terminus.
Comparison of the amino acid sequence of cytokeratin 15 with those of other proteins identified this polypeptide as a member of the acidic (type I) subfamily of cytokeratins (e.g., 36, 83) . It shows a particularly close relationship (Fig. 8) to the human cytokeratin 14 (76% identity in the rod region; 62% overall identity; 36, 61), and murine Mr 47,000 cytokeratin (85 % identical positions in the rod domain; 51) and the amphibian cytokeratin A~ of the XK81 gene subfamily (44, 63) . Surprisingly, it also shows a high similarity (74% identical positions in the rod) with the simple epithelial type I cytokeratin 19 from cow (2).
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Distribution of mRNAs for Cytokeratins 4 and 15 as Determined by In Situ Hybridization
To examine the expression of the genes encoding cytokeratins 4 and 15 in complex stratified tissues, we prepared radioactively labeled antisense RNA probes and used them for hybridization in situ. For example, we show the results obtained for esophagus. Intense reactions were seen for both mRNAs (Figs. 9 and 10), in particular when compared to the much weaker hybridization signals obtained with the probes for the simple epithelial type cytokeratins 8 and 18 (cf. 9). In autoradiographs using the cytokeratin 4 mRNA probe the label was spread over most of the epithelial cell layers (Fig.  9, a and b) but showed, in some regions, a reduction over the basal cell layer (Fig. 9 c) . Interestingly, in some epithelial regions the silver grain density was also drastically reduced in the upper, i.e., adluminal strata (Fig. 9 c) . The antisense riboprobe for cytokeratin 15 mRNA always yielded uniform hybridization in all cell layers of all samples examined (Fig. lO, a and b) , indicative of the presence of this mRNA in the entire epithelium, including the basal cell layer. The same signal distribution was seen after hybridization with the synthetic polynucleotide probe representing the 3'-noncoding region (Fig. l0 c) . Hybridization reactions were also seen over ductal epithelia traversing the lamina propria, particularly for cytokeratin 15 mRNA (Fig. lO b, 
arrow).
Similar results were obtained for other stratified epithelia such as exocervix (data not shown). Neither for cytokeratin 4 nor for cytokeratin 15 mRNA have we noticed regional intraepithelial heterogeneities of the kind recently described for murine tongue mucosa (76) .
Discussion
In this study we have introduced and characterized two DNA clones encoding cytokeratins 4 and 15 which are both typical for certain differentiation programs of stratified epithelia. Notably, cytokeratin 4, which usually occurs in heterotypic "pair" complexes with cytokeratin 13 (11, 23, 38, 87), has been described as a hallmark of a developmental line for certain squamous nonepidermal epithelia ("esophageal type of differentiation" sensu 11, 12, 87) .
The general molecular features of these two polypeptides are similar to those of other type II (polypeptide 4) and I (polypeptide 15) cytokeratins. Interestingly, both cytokeratins present a tail region with a comparatively low glycine content, unlike many other cytokeratins from squamous epi- thelia such as various epidermal cytokeratins of human, bovine, murine and amphibian origin (37, 39, 45, 47, 54, 79, 82, 83, 88) . The probes specific for the 3'-noncoding region of both cytokeratins, which react specifically with only one mRNA species in the various cells and tissues examined, should be valuable in studying gene expression programs related to the formation of stratified epithelia, including squamous metaplasia of simple epithelia, as well as in the characterization of various types of squamous cell carcinomas which may be distinguished by the presence or absence of cytokeratin 4 and/or cytokeratin 15 (for gel electrophoretic and immunocytochemical analyses see references 4, 5, 8, 31, 35, [64] [65] [66] [67] 91) .
The immunocytochemical results of the present study, as well as previous reports on the distribution of cytokeratin 4 in stratified tissues (22, 72, 91; see there also for similar data with cytokeratin 13 antibodies), have shown reduced or even absent reactions in the basal cell layer. This is reminiscent of the negative reactions of basal cell layers of epidermis obtained with antibodies to certain epidermal components, (10, 41, 47, 55, 81, 87, 95) . This has usually been interpreted to mean that the synthesis of these proteins is initiated only during or after commitment to vertical, i.e., suprabasal differentiation and is related to the transition of the specific cell from the basal to the suprabasal compartment (cf. 30). However, our in situ hybridizations show that mRNA for both stratification-related cytokeratins can be synthesized in all layers of esophagus, including the basal layer. Clearly, the gene encoding cytokeratin 15 is actively transcribed and cytokeratin 15 mRNA accumulated already in the basal cell layer. For cytokeratin 4, mRNA can also be seen in basal cells of some esophageal regions whereas other regions present only with low levels of mRNA in the basal compartment, which seems to correspond to the absence of immunocytochemically detectable amounts of this protein in basal layers of certain epithelia (this study; 22, 91) . The reasons for the observed regional heterogeneities of cytokeratin 4 expression in the basal cell layer as well as in adluminal cell layers are not known.
These results, together with those obtained for cytokeratins 8, 14, and 18 (9) , also indicate that at least in certain stratified epithelia commitment to suprabasal translocation and vertical cell differentiation can already commence in the basal cell layer and that the genes for both kinds of cytokeratins, the simple epithelial ones and the stratification-related ones, can be coexpressed, at least in certain regions. This also demonstrates that proliferation and expression of suprabasal marker proteins do not necessarily exclude each other. These conclusions also receive support from observations of the onset of synthesis of cytokeratin 4 in cell clusters of certain glands and glandular ducts (this study; 91), in individual cells of various simple and complex epithelia such as endocervix (22) and bronchial epithelium (91) , which may reflect early changes toward squamous metaplasia, and in certain layers of fetal human epidermis (92) . Noteworthy in this context are also observations that, in certain cells of squamous and transitional cell carcinomas, the simple epithelial cytokeratins 8 and 18 are often coexpressed with stratification-related ones such as cytokeratins 4-6 and 13-17, although often only focally (cf. 22, 91) . It will be important to examine, by in situ hybridization, whether such cellular heterogeneities are only due to immunocytochemical phenomena such as epitope masking (for examples with IF proteins, see 14, 16, 21, 26, 95) , or whether it is also evident at the mRNA level.
The observation of coexpression of simple epithelial cytokeratins and cytokeratins 4 and 15 in basal cells of certain stratified tissues also raise the question of the nature of the cytokeratin complexes present in these cells. It is well conceivable that these polypeptides, when present at low concentrations, as this is probably the case in the basal cells, can form heterotypic complexes with each other as well as with other complementary partners, as it has been shown by recombination of purified cytokeratins in vitro (18, 38) and by integration of mRNAs or cloned cytokeratin genes into cultured epithelial cells (25, 33) . The possible combination of cytokeratin 4 with type I cytokeratins other than cytokeratin 13 is also supported by reports of cells in which only cytokeratin 4 but not cytokeratin 13 has been detected such as amnion epithelium (75) , certain cells of cornea and pancreatic ducts (91) , some squamous cell carcinomas (5, 35, 65) , and fetal epidermis (92) . Vice versa, a number of cultured cell lines and squamous cell carcinomas synthesize considerable amounts of cytokeratin 13 without detectable cytokeratin 4 (1, 67, 77, 78) . This raises the question of the coordinate regulation of "pairs" of cytokeratins in some cell types as opposed to the noncoordinated synthesis of these polypeptides in other cells. The new cDNA probes described in this paper will hopefully contribute to the identification of the level of regulation at which such coordinations and disproportionate syntheses take place, also with respect to changes of expression due the environment (15, 50, 89) .
